Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 401 of 6351
-
New trial aims to wipe out hidden leukemia before transplant
Disease control Not yet recruitingThis phase II MyeloMATCH treatment trial compares cytarabine versus (vs.) cytarabine and venetoclax vs. liposome-encapsulated daunorubicin-cytarabine and venetoclax vs. azacitidine and venetoclax for treating patients who have residual disease after treatment for acute myeloid le…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New brain zaps aim to lift depression when meds fail
Symptom relief Not yet recruitingThe purpose of this study is to confirm the efficacy of two recently introduced repetitive transcranial magnetic stimulation (rTMS) interventions - accelerated intermittent theta-burst stimulation (aiTBS) and individualized neuronavigation - in treatment-resistant depression (TRD…
Sponsor: University of Texas Southwestern Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Exoskeleton and spinal zaps may rebuild muscle and bone after paralysis
Disease control Not yet recruitingImmobilization following spinal cord injury (SCI) results in muscle and bone loss below the level of injury, which ultimately predisposes to fracture at several sites throughout the legs and can lead to several medical complications that can devastate quality of life. There is a …
Sponsor: Bronx VA Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Stool test vs. colonoscopy: new trial aims to prevent colon cancer in High-Risk patients
Prevention Recruiting nowThe ULTRA-SAFE clinical trial is a prospective, randomized study designed to address the limitations of current "one-size-fits-all" colorectal cancer surveillance guidelines. While international standards recommend a three-year follow-up colonoscopy for all high-risk patients, da…
Sponsor: National Taiwan University Hospital • Aim: Prevention
Last updated Aug 28, 2026 00:00 UTC
-
New study to track gene Therapy's Real-World impact on spinal muscular atrophy
Disease control Not yet recruitingThe primary purpose is to address critical evidence in the treatment landscape for Spinal Muscular Atrophy (SMA), specifically focusing on the intrathecal formulation of onasemnogene abeparvovec-brve (ITVISMA®). U.S. Pragmatic Multicenter Study (STREAM).
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New oral drug could replace steroids for severe colitis Flare-Ups
Disease control Not yet recruitingThe goal of this clinical trial is to learn if the oral medication upadacitinib can safely and effectively treat acute severe ulcerative colitis (ASUC) in adults who are hospitalized. It will also evaluate whether upadacitinib can be used without corticosteroids during initial tr…
Phase 4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New Pre-Surgery combo aims to boost cancer fight in stomach and esophageal tumors
Disease control Not yet recruitingThis trial is designed to evaluate a total neoadjuvant approach using D-FLOT as the new standard backbone in patients with resectable esophagogastric adenocarcinoma. It addresses major limitations of current treatment paradigms, builds directly on the strong clinical signal from …
Phase 2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Heated chemo cocktail may boost immune attack on stomach cancer
Disease control Not yet recruitingPatients with locally advanced gastric cancer (LAGC), particularly those with serosal invasion, remain at high risk of peritoneal recurrence despite standard perioperative treatment. Hyperthermic intraperitoneal chemotherapy (HIPEC) may eradicate free intraperitoneal tumor cells …
Phase 2 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug cocktail aims to tame deadly bile duct cancer
Disease control Not yet recruitingThis is a single-arm, multicenter clinical study designed to evaluate the efficacy and safety of Iparomlimab and Toripalimab (QL1706) in combination with bevacizumab and chemotherapy as first-line treatment for patients with advanced biliary tract cancer
Phase 4 • Sponsor: Xianglin Yuan • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New antibody drug aims to outsmart tumors by targeting two immune pathways
Disease control Not yet recruitingFG-B901 is a recombinant humanized IgG2 bispecific antibody targeting PD-L1 and CD40. It is designed to provide PD-L1-dependent CD40 agonism, thereby enhancing selectivity for the tumor microenvironment and reducing systemic toxicity compared with conventional CD40 agonists. Prec…
Phase 1/2 • Sponsor: FutureGen Biopharmaceutical (Beijing) Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Promising drug cocktail eyed for Tough-to-Treat urinary cancer
Disease control By invitation onlyThe combination of Enfortumab Vedotin and Pembrolizumab has substantially improved outcomes for patients with advanced urothelial carcinoma and has emerged as a new standard of care in the first-line setting. However, data specifically regarding its use in patients with Upper Tra…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Dual immunotherapy plus chemo may shrink cervical tumors before surgery
Disease control Recruiting nowPurpose: To evaluate the efficacy and safety of neoadjuvant treatment with iparomlimab and tuvonralimab (QL1706), a dual PD1and CTLA4 bispecific antibody, in combination with paclitaxel and either cisplatin or carboplatin (TP/TC regimen) for patients with locally advanced cervic…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
AI could outshine standard tumor measurements to predict survival
Knowledge-focused Not yet recruitingPurpose: This study is developing and validating an artificial intelligence (AI)-driven system to evaluate tumor response using changes in total tumor volume. The goal is to determine whether this AI-based approach can better predict patient survival compared with the current sta…
Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Spinal pain pump may offer relief for cancer patients when opioids fail
Symptom relief Recruiting nowApproximately 66% of patients with advanced cancer experience pain, which is often inadequately controlled and associated with a decline in health-related quality of life (HRQoL). Conventional pharmacologic management, ranging from simple analgesics to strong opioids, is frequent…
Sponsor: Universitair Ziekenhuis Brussel • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Could a prebiotic diet boost brain development in preterm babies?
Disease control Not yet recruitingThe purpose of this randomized controlled trial is to evaluate the effect of a structured, high-prebiotic dietary pattern on the neurodevelopmental outcomes of preterm infants. The intervention lasts for 6 months and aims to promote the growth of endogenous beneficial gut bacteri…
Sponsor: Fudan University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Can mapping migrant networks help end neglected tropical diseases?
Disease control Recruiting nowNeglected Tropical Diseases (NTDs) are among the most common groups of diseases affecting over one billion people globally and are disproportionately concentrated in remote, underserved, and marginalized communities. Efforts toward NTD elimination have largely relied on preventiv…
Sponsor: Uwemedimo Friday Ekpo • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Veggies first, carbs last: could meal and exercise order be the key to childhood weight loss?
Disease control Not yet recruitingThe goal of this clinical trial is to learn how the order of exercise and the order of eating food affect weight management in overweight and obese children and adolescents. The main questions it aims to answer are whether doing aerobic or anaerobic exercise first changes weight …
Sponsor: Peking University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New drug could offer safer option after prostate cancer surgery
Disease control Recruiting nowProstate cancer patients with high-risk features who undergo radical prostatectomy (RP) are at a significant risk of biochemical recurrence (BCR) and disease progression. While adjuvant androgen deprivation therapy (ADT) with or without radiotherapy is the current standard of car…
Phase 2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
AI reads knee ultrasounds to predict injection success
Diagnosis Recruiting nowThis study aims to develop and validate an artificial intelligence (AI)-assisted platform for musculoskeletal knee ultrasonography and to establish an interpretable prediction model for clinical outcomes following ultrasound-guided injection therapies in patients with degenerativ…
Sponsor: National Taiwan University Hospital • Aim: Diagnosis
Last updated Jul 24, 2026 00:00 UTC
-
Can AI be a Pathologist's second opinion?
Diagnosis By invitation onlyThis study will evaluate whether artificial intelligence (AI) can enhance clinicians' accuracy, efficiency, and confidence in distinguishing lung adenocarcinoma (LUAD) from lung squamous cell carcinoma (LUSC) and kidney renal papillary cell carcinoma (KIRP) from kidney renal clea…
Sponsor: Harvard Medical School (HMS and HSDM) • Aim: Diagnosis
Last updated Aug 05, 2026 00:00 UTC